STOCK TITAN

Insider schedules sale of common shares in issuer (NASDAQ: VCEL) stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

This Form 144 notice discloses a planned sale of 10,000 shares of common stock in the issuer by Michael Halpin. The shares are to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 01/07/2026 and an aggregate market value of 404,832.95.

The 10,000 shares were acquired on 01/07/2026 via a cash exercise of a stock option that was granted on 02/06/2019 by the issuer. The notice also reports that, in the past three months, Halpin sold additional common shares: 7,358 shares on 11/06/2025 for gross proceeds of 297,774.58, and 2,642 shares on 11/11/2025 for gross proceeds of 106,759.79.

By signing the notice, the selling holder represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for VCEL disclose?

The notice discloses that Michael Halpin intends to sell 10,000 shares of common stock of the issuer on the NASDAQ, through Fidelity Brokerage Services LLC, with an approximate sale date of 01/07/2026 and an aggregate market value of 404,832.95.

How were the 10,000 VCEL shares being sold under Form 144 acquired?

The 10,000 common shares were acquired on 01/07/2026 through a cash exercise of a stock option that was originally granted on 02/06/2019 by the issuer.

What prior sales by the insider are reported in this VCEL Form 144?

Over the prior three months, Michael Halpin sold issuer common stock in two transactions: 7,358 shares on 11/06/2025 for gross proceeds of 297,774.58 and 2,642 shares on 11/11/2025 for gross proceeds of 106,759.79.

What trading representation does the seller make in this VCEL Form 144?

The seller represents that they do not know any material adverse information regarding the issuer’s current or prospective operations that has not been publicly disclosed, as required in the Form 144 notice.

On which exchange and through which broker are the VCEL shares expected to be sold?

The planned 10,000-share sale of common stock is listed to occur on the NASDAQ through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

How many shares of the issuer’s common stock are reported as outstanding in this Form 144?

The Form 144 indicates that there are 50,574,026 shares of the issuer’s common stock outstanding at the time of the notice.

Vericel

NASDAQ:VCEL

VCEL Rankings

VCEL Latest News

VCEL Latest SEC Filings

VCEL Stock Data

1.95B
50.04M
1.06%
111.18%
10.91%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE